Jakko van Ingen

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 70

Top Venues

Antimicrobial agents and chemotherapy

The European respiratory journal

Journal of clinical microbiology

ERJ open research

Radboudumc (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Radboudumc Jan 25 2016

Netherlands

PHD :: Medical Microbiology

Radboudumc Jan 01 2011 - Jan 25 2016

Netherlands

PHD :: Medical Microbiology

Rijksinstituut voor Volksgezondheid en Milieu Jan 01 2008 - Jul 31 2010

Netherlands

PHD :: Tuberculosis Reference Unit

Radboudumc Apr 01 2005 - Sep 21 2009

Netherlands

PHD :: Pulmonary Diseases

Publications

Stefano Aliberti, Francesco Blasi, Pierre Regis Burgel, Andrea Calcagno, Andreas Fløe, Dorothy Grogono, Apostolos Papavasileiou, Eva Polverino, Concepción Prados, Gernot G U Rohde, Helmut J F Salzer, Adrián Sánchez-Montalvá, Michal Shteinberg, Eva Van Braeckel, Jakko van Ingen, Nicolas Veziris, Dirk Wagner, Michael R Loebinger
Mycobacterium avium complex pulmonary disease patients with limited treatment options. ERJ open research 10 (1) (2024)
Jakko van Ingen
Why do we use 100 mg of clofazimine in TB and NTM treatment? The Journal of antimicrobial chemotherapy 79 (4) (2024)
Jakko van Ingen, Wouter Hoefsloot, Véronique Dartois, Thomas Dick
Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint. The European respiratory journal 63 (5) (2024)
Jakko van Ingen
Why do we use 100 mg of clofazimine in TB and NTM treatment? The Journal of antimicrobial chemotherapy 79 (4) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy (2024)
Stefano Aliberti, Francesco Blasi, Pierre Regis Burgel, Andrea Calcagno, Andreas Fløe, Dorothy Grogono, Apostolos Papavasileiou, Eva Polverino, Concepción Prados, Gernot G U Rohde, Helmut J F Salzer, Adrián Sánchez-Montalvá, Michal Shteinberg, Eva Van Braeckel, Jakko van Ingen, Nicolas Veziris, Dirk Wagner, Michael R Loebinger
Mycobacterium avium complex pulmonary disease patients with limited treatment options. ERJ open research 10 (1) (2024)
Jakko van Ingen, Wouter Hoefsloot, Véronique Dartois, Thomas Dick
Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint. The European respiratory journal 63 (5) (2024)
Jakko van Ingen, Wouter Hoefsloot, Véronique Dartois, Thomas Dick
Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint. The European respiratory journal 63 (5) (2024)
Jakko van Ingen
Why do we use 100 mg of clofazimine in TB and NTM treatment? The Journal of antimicrobial chemotherapy (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jakko van Ingen
Why do we use 100 mg of clofazimine in TB and NTM treatment? The Journal of antimicrobial chemotherapy 79 (4) (2024)
Jakko van Ingen
Why do we use 100 mg of clofazimine in TB and NTM treatment? The Journal of antimicrobial chemotherapy 79 (4) (2024)
Jakko van Ingen, Wouter Hoefsloot, Véronique Dartois, Thomas Dick
Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint. The European respiratory journal 63 (5) (2024)
Michael R Loebinger, Roald van der Laan, Marko Obradovic, Jakko van Ingen
Global survey of physician testing practices for nontuberculous mycobacteria. ERJ open research 9 (3) (2023)
Jodie Anne Schildkraut, Jordy P M Coolen, Heleen Severin, Ellen Koenraad, Nicole Aalders, Willem J G Melchers, Wouter Hoefsloot, Heiman F L Wertheim, Jakko van Ingen
MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care. Journal of clinical microbiology 61 (3) (2023)
Jodie Anne Schildkraut, Jordy P M Coolen, Heleen Severin, Ellen Koenraad, Nicole Aalders, Willem J G Melchers, Wouter Hoefsloot, Heiman F L Wertheim, Jakko van Ingen
MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care. Journal of clinical microbiology (2023)
David Rodríguez-Temporal, Laura Herrera, Fernando Alcaide, Diego Domingo, Genevieve Héry-Arnaud, Jakko van Ingen, An Van den Bossche, André Ingebretsen, Clémence Beauruelle, Eva Terschlüsen, Samira Boarbi, Neus Vila, Manuel J Arroyo, Gema Méndez, Patricia Muñoz, Luis Mancera, María Jesús Ruiz-Serrano, Belén Rodríguez-Sánchez
Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning. Journal of clinical microbiology 61 (1) (2023)
Jodie Anne Schildkraut, Jordy P M Coolen, Heleen Severin, Ellen Koenraad, Nicole Aalders, Willem J G Melchers, Wouter Hoefsloot, Heiman F L Wertheim, Jakko van Ingen
MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care. Journal of clinical microbiology 61 (3) (2023)
Jodie Anne Schildkraut, Jordy P M Coolen, Heleen Severin, Ellen Koenraad, Nicole Aalders, Willem J G Melchers, Wouter Hoefsloot, Heiman F L Wertheim, Jakko van Ingen
MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care. Journal of clinical microbiology 61 (3) (2023)
Ralf Stemkens, Maarten Cobussen, Erik de Laat, Wouter Hoefsloot, Reinout van Crevel, Rob E Aarnoutse, Jakko van Ingen
Successful addition of topical antibiotic treatment after surgery in treatment-refractory nontuberculous mycobacterial skin and soft tissue infections. Antimicrobial agents and chemotherapy (2023)
David Rodríguez-Temporal, Laura Herrera, Fernando Alcaide, Diego Domingo, Genevieve Héry-Arnaud, Jakko van Ingen, An Van den Bossche, André Ingebretsen, Clémence Beauruelle, Eva Terschlüsen, Samira Boarbi, Neus Vila, Manuel J Arroyo, Gema Méndez, Patricia Muñoz, Luis Mancera, María Jesús Ruiz-Serrano, Belén Rodríguez-Sánchez
Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning. Journal of clinical microbiology 61 (1) (2023)
David Rodríguez-Temporal, Laura Herrera, Fernando Alcaide, Diego Domingo, Genevieve Héry-Arnaud, Jakko van Ingen, An Van den Bossche, André Ingebretsen, Clémence Beauruelle, Eva Terschlüsen, Samira Boarbi, Neus Vila, Manuel J Arroyo, Gema Méndez, Patricia Muñoz, Luis Mancera, María Jesús Ruiz-Serrano, Belén Rodríguez-Sánchez
Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning. Journal of clinical microbiology 61 (1) (2023)
David Rodríguez-Temporal, Laura Herrera, Fernando Alcaide, Diego Domingo, Genevieve Héry-Arnaud, Jakko van Ingen, An Van den Bossche, André Ingebretsen, Clémence Beauruelle, Eva Terschlüsen, Samira Boarbi, Neus Vila, Manuel J Arroyo, Gema Méndez, Patricia Muñoz, Luis Mancera, María Jesús Ruiz-Serrano, Belén Rodríguez-Sánchez
Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning. Journal of clinical microbiology (2023)
David Rodríguez-Temporal, Laura Herrera, Fernando Alcaide, Diego Domingo, Genevieve Héry-Arnaud, Jakko van Ingen, An Van den Bossche, André Ingebretsen, Clémence Beauruelle, Eva Terschlüsen, Samira Boarbi, Neus Vila, Manuel J Arroyo, Gema Méndez, Patricia Muñoz, Luis Mancera, María Jesús Ruiz-Serrano, Belén Rodríguez-Sánchez
Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning. Journal of clinical microbiology 61 (1) (2023)
Jodie Anne Schildkraut, Jelmer Raaijmakers, Rob Aarnoutse, Wouter Hoefsloot, Heiman F L Wertheim, Jakko van Ingen
The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease. Antimicrobial agents and chemotherapy (2023)
David Rodríguez-Temporal, Laura Herrera, Fernando Alcaide, Diego Domingo, Genevieve Héry-Arnaud, Jakko van Ingen, An Van den Bossche, André Ingebretsen, Clémence Beauruelle, Eva Terschlüsen, Samira Boarbi, Neus Vila, Manuel J Arroyo, Gema Méndez, Patricia Muñoz, Luis Mancera, María Jesús Ruiz-Serrano, Belén Rodríguez-Sánchez
Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning. Journal of clinical microbiology 61 (1) (2023)
Michael R Loebinger, Roald van der Laan, Marko Obradovic, Jakko van Ingen
Global survey of physician testing practices for nontuberculous mycobacteria. ERJ open research 9 (3) (2023)
Michael R Loebinger, Roald van der Laan, Marko Obradovic, Jakko van Ingen
Global survey of physician testing practices for nontuberculous mycobacteria. ERJ open research 9 (3) (2023)
Louise Hendrikx, Colette L M van Hees, Jurriaan E M De Steenwinkel, Hannelore I Bax, Tom Sprong, Bert Mulder, Arjan Jansz, Arjanne van Griethuysen, Ron Bosboom, Annette Stemerding, Marjolein Koetsier, Marco van Coevorden, Bas C Mourik, Koen D Quint, Alewijn Ott, Dick van Soolingen, Saskia Kuipers, Reinout van Crevel, Jakko van Ingen
Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease. Open forum infectious diseases 9 (4) (2022)
Jakko van Ingen, Stefano Aliberti, Claire Andrejak, James D Chalmers, Luigi R Codecasa, Charles L Daley, Naoki Hasegawa, David E Griffith, Wouter Hoefsloot, Gwen Huitt, Julie Jarand, Byung Woo Jhun, Michael R Loebinger, Theodore K Marras, Kozo Morimoto, Eva Polverino, Felix C Ringshausen, Miguel Santin, Rachel Thomson, Dirk Wagner, Richard J Wallace, Kevin L Winthrop, Jae-Joon Yim
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (1) (2021)
James D Chalmers, Jakko van Ingen, Roald van der Laan, Jean-Louis Herrmann
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections. European respiratory review : an official journal of the European Respiratory Society 30 (161) (2021)
Sanne M H Zweijpfenning, Stephan E P Kops, Martin J Boeree, Saskia Kuipers, Jakko van Ingen, Wouter Hoefsloot, Cecile Magis-Escurra
Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study. ERJ open research 7 (4) (2021)
Jodie Anne Schildkraut, Jordy P M Coolen, Sophie Burbaud, Jasper J N Sangen, Michael P Kwint, R Andres Floto, Huub J M Op den Camp, Lindsey H M Te Brake, Heiman F L Wertheim, Kornelia Neveling, Wouter Hoefsloot, Jakko van Ingen
RNA-sequencing elucidates drug-specific mechanisms of antibiotic tolerance and resistance in M. abscessus. Antimicrobial agents and chemotherapy (2021)
Dirk Wagner, Jakko van Ingen, Roald van der Laan, Marko Obradovic, null null
Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey. BMJ open respiratory research 7 (1) (2021)
Jodie Anne Schildkraut, Sanne Maria Henriëtte Zweijpfenning, Martijn Nap, Kun He, Elena Dacheva, Jetty Overbeek, Alma Tostmann, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands. ERJ open research 7 (3) (2021)
Jelmer Raaijmakers, Jodie Anne Schildkraut, Wouter Hoefsloot, Jakko van Ingen
The role of amikacin in the treatment of nontuberculous mycobacterial disease. Expert opinion on pharmacotherapy 22 (15) (2021)
Zahra Sadouki, Timothy D McHugh, Rob Aarnoutse, Julio Ortiz Canseco, Christopher Darlow, William Hope, Jakko van Ingen, Christopher Longshaw, Davide Manissero, Andrew Mead, Ludovic Pelligand, Lynette Phee, John Readman, Mike Marvin Ruth, Joseph F Standing, Neil Stone, Emmanuel Q Wey, Frank Kloprogge
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting. The Journal of antimicrobial chemotherapy 76 (9) (2021)
Kevin L Winthrop, Patrick A Flume, Rachel M Thomson, Kevin C Mange, Dayton W Yuen, Monika Ciesielska, Kozo Morimoto, Stephen J Ruoss, Luigi R Codecasa, Jae-Joon Yim, Theodore K Marras, Jakko van Ingen, Richard J Wallace, Barbara A Brown-Elliott, Chris Coulter, David E Griffith
Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial. Annals of the American Thoracic Society 18 (7) (2021)
Lian J Pennings, Mike Marvin Ruth, Heiman F L Wertheim, Jakko van Ingen
The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria. Antimicrobial agents and chemotherapy 65 (4) (2021)
Mike Marvin Ruth, Lian J Pennings, Valerie A C M Koeken, Jodie A Schildkraut, Aria Hashemi, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Thioridazine Is an Efflux Pump Inhibitor in Mycobacterium avium Complex but of Limited Clinical Relevance. Antimicrobial agents and chemotherapy 64 (7) (2020)
Mariolina Bruno, Sanne M H Zweijpfenning, Jeske Verhoeven, Martin J Boeree, Mihai G Netea, Frank L van de Veerdonk, Jakko van Ingen, Wouter Hoefsloot
Subtle immunodeficiencies in nodular-bronchiectatic Mycobacterium avium complex lung disease. ERJ open research 6 (4) (2020)
Carolien Ruesen, Lidya Chaidir, Cesar Ugarte-Gil, Jakko van Ingen, Julia A Critchley, Philip C Hill, Rovina Ruslami, Prayudi Santoso, Martijn A Huynen, Hazel M Dockrell, David A J Moore, Bachti Alisjahbana, Reinout van Crevel
Diabetes is associated with genotypically drug-resistant tuberculosis. The European respiratory journal 55 (3) (2020)
Ayesha J Verrall, Lidya Chaidir, Carolien Ruesen, Lika Apriani, Raspati C Koesoemadinata, Jakko van Ingen, Katrina Sharples, Reinout van Crevel, Bachti Alisjahbana, Philip C Hill, null null
Lower Bacillus Calmette-Guérin Protection against Mycobacterium tuberculosis Infection after Exposure to Beijing Strains. American journal of respiratory and critical care medicine 201 (9) (2020)
Charles L Daley, Jonathan M Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J Wallace, Claire Andrejak, Erik C Böttger, Jan L Brozek, David E Griffith, Lorenzo Guglielmetti, Gwen A Huitt, Shandra L Knight, Philip Leitman, Theodore K Marras, Kenneth N Olivier, Miguel Santin, Jason E Stout, Enrico Tortoli, Jakko van Ingen, Dirk Wagner, Kevin L Winthrop
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. The European respiratory journal 56 (1) (2020)
Pieter Ekermans, Rene de Gama, Celeste Kock, Ebrahim Hoosien, Tomas Slavik, Terry Marshall, Craig Corcoran, Jakko van Ingen
An unusual case of abdominal mycobacterial infection: Case report and literature review. Southern African journal of HIV medicine 20 (1) (2019)
Mariëlle Rockland, Mike Marvin Ruth, Nicole Aalders, Lian J Pennings, Wouter Hoefsloot, Melanie Wattenberg, Jakko van Ingen
Implementation of Semiautomated Antimicrobial Susceptibility Interpretation Hardware for Nontuberculous Mycobacteria May Overestimate Susceptibility. Journal of clinical microbiology 57 (4) (2019)
Enrico Tortoli, Barbara A Brown-Elliott, James D Chalmers, Daniela Maria Cirillo, Charles L Daley, Stefan Emler, R Andres Floto, Maria J Garcia, Wouter Hoefsloot, Won-Jung Koh, Christoph Lange, Michael Loebinger, Florian P Maurer, Kozo Morimoto, Stefan Niemann, Elvira Richter, Christine Y Turenne, Ravikiran Vasireddy, Sruthi Vasireddy, Dirk Wagner, Richard J Wallace, Nancy Wengenack, Jakko van Ingen
Same meat, different gravy: ignore the new names of mycobacteria. The European respiratory journal 54 (1) (2019)
Anne Huiberts, Sanne M H Zweijpfenning, Lian J Pennings, Martin J Boeree, Jakko van Ingen, Cecile Magis-Escurra, Wouter Hoefsloot
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease. The European respiratory journal 54 (1) (2019)
Cornelia A M van de Weg, Jurriaan E M de Steenwinkel, Jelle R Miedema, Marleen Bakker, Jakko van Ingen, Wouter Hoefsloot
The tough process of unmasking the slow-growing mycobacterium: case report of Mycobacterium microti infection. Access microbiology 2 (1) (2019)
Steven Cowman, Jakko van Ingen, David E Griffith, Michael R Loebinger
Non-tuberculous mycobacterial pulmonary disease. The European respiratory journal 54 (1) (2019)
Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, Geoffrey Eather, Regina Gayoso, Naoki Hasegawa, Byung Woo Jhun, Won-Jung Koh, Ho Namkoong, Jimyung Park, Rachel Thomson, Jakko van Ingen, Sanne M H Zweijpfenning, Jae-Joon Yim
M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis. The European respiratory journal 54 (1) (2019)
Floor van Wijk, Jérôme Waterval, Koen van Aerde, Stefanie S V Henriet, F J Anton Meijer, Lennaert C Borra, Rob E Aarnoutse, Jakko van Ingen
Successful Systemic and Topical Treatment of Mycobacterium abscessus Otomastoiditis. Antimicrobial agents and chemotherapy 64 (1) (2019)
Mike Marvin Ruth, Mara van Rossum, Valerie A C M Koeken, Lian J Pennings, Elin M Svensson, Carolien Ruesen, Edmee C Bowles, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus. Antimicrobial agents and chemotherapy 63 (9) (2019)
Saskia Kuipers, Mike Marvin Ruth, Mike Mientjes, Ruud G L de Sévaux, Jakko van Ingen
A Dutch Case Report of Successful Treatment of Chronic Relapsing Urinary Tract Infection with Bacteriophages in a Renal Transplant Patient. Antimicrobial agents and chemotherapy 64 (1) (2019)
Sanne M H Zweijpfenning, Jodie A Schildkraut, Jordy P M Coolen, Carolien Ruesen, Ellen Koenraad, Anne Janssen, Mike M Ruth, Arjan S de Jong, Saskia Kuipers, Rob E Aarnoutse, Cecile Magis-Escurra, Wouter Hoefsloot, Jakko van Ingen
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease. The European respiratory journal 54 (1) (2019)
Kim Geurts, Sanne M H Zweijpfenning, Lian J Pennings, Jodie A Schildkraut, Martin J Boeree, Cecile Magis-Escurra, Henrich van der Lee, Paul E Verweij, Wouter Hoefsloot, Jakko van Ingen
Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde? The European respiratory journal 54 (1) (2019)
Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L Daley, Geoffrey Eather, Naoki Hasegawa, Won-Jung Koh, Rachel Thomson, Jakko van Ingen, Jae-Joon Yim
Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics? The European respiratory journal 54 (5) (2019)
Carolien Ruesen, Anca Lelia Riza, Adriana Florescu, Lidya Chaidir, Cornelia Editoiu, Nicole Aalders, Dragos Nicolosu, Victor Grecu, Mihai Ioana, Reinout van Crevel, Jakko van Ingen
Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania. Scientific reports 8 (1) (2018)
Zofia Bakuła, Magdalena Modrzejewska, Lian J Pennings, Małgorzata Proboszcz, Aleksandra Safianowska, Jacek Bielecki, Jakko van Ingen, Tomasz Jagielski
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii. Antimicrobial agents and chemotherapy 62 (4) (2018)
Jakko van Ingen, Timothy Aksamit, Claire Andrejak, Erik C Böttger, Emmanuelle Cambau, Charles L Daley, David E Griffith, Lorenzo Guglielmetti, Steven M Holland, Gwen A Huitt, Won-Jung Koh, Christoph Lange, Philip Leitman, Theodore K Marras, Kozo Morimoto, Kenneth N Olivier, Miguel Santin, Jason E Stout, Rachel Thomson, Enrico Tortoli, Richard J Wallace, Kevin L Winthrop, Dirk Wagner, null null
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. The European respiratory journal 51 (3) (2018)
Mike Marvin Ruth, Jasper J N Sangen, Lian J Pennings, Jodie A Schildkraut, Wouter Hoefsloot, Cecile Magis-Escurra, Heiman F L Wertheim, Jakko van Ingen
Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease. Antimicrobial agents and chemotherapy 62 (10) (2018)
Sanne M H Zweijpfenning, Hester van Groningen, Jakko van Ingen, Cecile Magis-Escurra, Martin J Boeree, Dirk Wagner, Hannelore Bax, Claire Andrejak, Reinier Wener, Ananna Rahman, Heinke Kunst, Natalie Lorent, Marc A Brouwer, Wouter Hoefsloot, null null
Clofazimine does not lead to significant QT interval prolongation: a multicentre study. The European respiratory journal 52 (5) (2018)
Jakko van Ingen, Dirk Wagner, Jack Gallagher, Kozo Morimoto, Christoph Lange, Charles S Haworth, R Andres Floto, Jennifer Adjemian, D Rebecca Prevots, David E Griffith, null null
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. The European respiratory journal 49 (2) (2017)
Mike Marvin Ruth, Jasper Jan Nicolaas Sangen, Heiman Frank Louis Wertheim, Jakko van Ingen
Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria. Antimicrobial agents and chemotherapy 61 (9) (2017)
Paulina Borówka, Jakub Lach, Zofia Bakuła, Jakko van Ingen, Aleksandra Safianowska, Anna Brzostek, Jarosław Dziadek, Dominik Strapagiel, Tomasz Jagielski
Draft Genome Sequences of Mycobacterium kansasii Clinical Strains. Genome announcements 5 (22) (2017)
Dominik Strapagiel, Paulina Borówka, Błażej Marciniak, Zofia Bakuła, Jakko van Ingen, Aleksandra Safianowska, Anna Brzostek, Jarosław Dziadek, Tomasz Jagielski
Draft Genome Sequences of Mycobacterium kansasii Strains 1010001454, 1010001458, 1010001468, 1010001493, 1010001495, and 1010001469, Isolated from Environmental Sources. Genome announcements 4 (3) (2016)
Beatriz E Ferro, Shashikant Srivastava, Devyani Deshpande, Jotam G Pasipanodya, Dick van Soolingen, Johan W Mouton, Jakko van Ingen, Tawanda Gumbo
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. Antimicrobial agents and chemotherapy 60 (10) (2016)
Kim van Eck, Dirk Faro, Melanie Wattenberg, Arjan de Jong, Saskia Kuipers, Jakko van Ingen
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Fails To Identify Nontuberculous Mycobacteria from Primary Cultures of Respiratory Samples. Journal of clinical microbiology 54 (7) (2016)

Jakko van Ingen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jakko van Ingen